Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: The Scandinavian Prostate Cancer Group-4 randomised trial

The Lancet Oncology

Volumn 12, Issue 9, 2011, Pages 891-899

  Johansson, Eva ^a   Steineck, Gunnar ^b,c   Holmberg, Lars ^d   Johansson, Jan Erik ^e   Nyberg, Tommy ^b   Ruutu, Mirja ^f   Bill Axelson, Anna ^a,b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BLADDER FUNCTION; CANCER RISK; CHILD; CLINICAL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; EDUCATION; ERECTILE DYSFUNCTION; ETHNIC GROUP; FINNISH; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MENTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEXUAL DYSFUNCTION; SOCIAL STATUS; STRESS; SWEDISH; SYMPTOMATOLOGY; URINE INCONTINENCE; WATCHFUL WAITING;

AGED; AGED, 80 AND OVER; ANXIETY; ERECTILE DYSFUNCTION; FINLAND; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; URINARY INCONTINENCE; WATCHFUL WAITING;

EID: 80052368164     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70162-0     Document Type: Article

References (30)

1. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011, 364:1708-1717. for the Scandinavian Prostate Cancer Group Study No. 4.
2. Draisma G, Boer R, Otto SJ, et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003, 95:868-878.
3. Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009, 101:374-383.
4. Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002, 347:790-796.
5. Johansson E, Bill-Axelson A, Holmberg L, Onelöv E, Johansson JE, Steineck G Time, symptom burden, androgen deprivation and self-assessed quality of life after radical prostatectomy or watchful waiting: The randomized Scandinavian prostate cancer group study number 4 (SPCG-4). Eur Urol 2009, 55:422-430.
6. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002, 347:781-789.
7. TNM classification of malignant tumours 1978, International Union Against Cancer, Geneva, Switzerland. 3rd edn. M.H. Harmer (Ed.).
8. Stanne J, Johansson E, Nilsson A, et al. Inguinal hernia after radical prostatectomy for prostate cancer: results from a randomized setting and a nonrandomized setting. Eur Urol 2010, 58:719-726.
9. Nilsson AE, Schumacher MC, Johansson E, et al. Age at surgery, educational level and long-term urinary incontinence after radical prostatectomy. BJU Int 2011, published online May 19. 10.1111/j.1464-410X.2011.10231.x.
10. Kreicbergs U, Valdimirsdòttir U, Onelöv E, Henter JI, Steineck G Talking about death with children who have severe malignant disease. N Engl J Med 2004, 351:1175-1186.
11. Bergmark K, Åvall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 1999, 340:1383-1389.
12. Steineck G, Bergmark K, Henningsohn L, al-Abany M, Dickman PW, Helgason À Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncol 2002, 41:244-252.
13. Steineck G, Hunt H, Adolfsson J A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods. Acta Oncol 2006, 45:421-429.
14. McNutt L, Wu C, Xue X, Hafner JP Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003, 157:940-943.
15. Sprent P, Smeeton NC Chapter 4.1.3. Applied nonparametric statistical methods 2001, 127-129. Chapman & Hall/CRC, London, UK. 3rd edn.
16. Penson DF, McLerran D, Feng Z, et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol 2008, 179(suppl):S40-S44.
17. Hu JC, Gu X, Lipsitz SR Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 2009, 302:1557-1564.
18. Walsh PC, Donker PJ Impotence following radical prostatectomy; insight into etiologic and prevention. J Urol 1982, 128:492-497.
19. Ayyathurai R, Manoharan M, Nieder AM, Kava B, Soloway MS Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients. BJU Int 2008, 101:833-836.
20. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 2003, 21:401-405.
21. Bianco FJ, Riedel ER, Begg CB, Kattan MW, Scardino PT Variation among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol 2005, 173:2099-2103.
22. Denberg TD, Flanigan RC, Kim FJ, Hoffman RM, Steiner JF Self-reported volume of radical prostatectomies among urologists in the USA. BJU Int 2007, 99:339-343.
23. Beckman N, Waern M, Gustafsson D, Skoog I Secular trends in self reported sexual activity and satisfaction in Swedish 70 year olds: cross sectional survey of four populations, 1971-2001. BMJ 2008, 337:a279.
24. Lindau ST, Gavrilova N Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing. BMJ 2010, 340:c810.
25. Dalkin BL, Christopher BA Potent men undergoing radical prostatectomy: a prospective study measuring sexual health outcomes and the impact of erectile dysfunction treatments. Urol Oncol 2008, 26:281-285.
26. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003, 44:637-649.
27. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008, 358:1250-1261.
28. Bill-Axelsson A, Garmo H, Nyberg UK, et al. Psychiatric treatment in men with prostate cancer-results from a nation-wide, population-based cohort study from PcBaSe Sweden. Eur J Cancer 2011, published online May 23. 10.1016/j.ejca.2011.04.022.
29. Smith DP, King MT, Egger S, et al. Quality of life three years after diagnosis of localized prostate cancer: population based cohort study. BMJ 2009, 339:b4817-b4829.
30. Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: update 2010. CA Cancer J Clin 2010, 60:70-98.